Going-concern and financing risk
The company has not generated revenue and expects to need additional capital to fund operations.
- Scope
- Corporate liquidity and continuity of operations
- Materiality
- high
NewHydrogen, Inc.
NewHydrogen, Inc. is a U.S.-based clean energy technology developer focused on thermochemical green hydrogen production. The company is developing ThermoLoop™ with research support at UC Santa Barbara, and it has also previously worked on material technology for photovoltaic solar modules.
147.45
147.45
| % | |
|---|---|
| Thermochemical hydrogen technology | 70% Development of ThermoLoop™ and related water-splitting systems for low-cost green hydrogen production. |
| Clean energy R&D services | 20% Research and development work tied to materials, process design, and prototype advancement. |
| Solar materials technology | 10% Earlier-stage photovoltaic material technology aimed at improving solar module economics. |
NewHydrogen is primarily a development-stage company, so its direct customer base is limited and not yet commercialized...
- Future industrial hydrogen usersprimary
Potential buyers of low-cost green hydrogen for fertilizers, refining, steel, and chemicals.
- Strategic partners and licenseessecondary
Companies that may collaborate on development, pilot deployment, or commercialization of ThermoLoop™.
- Research and academic collaboratorssecondary
University and lab partners that help test materials and validate the technology.
- Capital providersprimary
Equity investors that fund ongoing R&D and corporate overhead before revenue generation.
The company is based in the United States and operates from Los Angeles, California. Its current development work is...
- •Headquartered in Los Angeles, California
- •Development program tied to UC Santa Barbara
- •Current operations are concentrated in the United States
- •Target market for hydrogen technology is global
- •No disclosed country-level revenue because the company has no revenue
The company’s near-term strategy is to preserve and advance the ThermoLoop™ development program while managing cash...
01
Continue ThermoLoop™ developmentshort-term
The company’s value proposition depends on proving the technology can produce hydrogen at lower cost.
02
Secure external financingshort-term
The company needs capital to fund R&D and general corporate expenses before revenue generation.
03
Move toward commercializationmedium-term
Commercial adoption is needed to convert the technology platform into a sustainable business.
The company is pre-revenue and depends on external financing to continue operations, which creates substantial...
Technology development risk
ThermoLoop™ is still in development, so technical feasibility, scale-up, and cost targets remain uncertain.
- Scope
- R&D program and future commercialization
- Materiality
- high
Dilution from equity financing
Management expects to fund the business through securities issuance, which can dilute existing holders.
- Scope
- Shareholder value and capital structure
- Materiality
- high
Market adoption risk
Even if the technology works, customers may prefer established hydrogen production methods.
- Scope
- Commercialization and revenue conversion
- Materiality
- medium
Valuation and estimate risk
Fair value estimates for stock options and derivative liabilities can be volatile and judgmental.
- Scope
- Reported earnings and balance sheet values
- Materiality
- medium
Fair value of stock options and derivatives
Can create volatile non-cash gains or losses
Impairment of intangible and fixed assets
Could reduce asset values and increase losses
Deferred tax valuation allowance
Affects net deferred tax assets and tax expense
Going-concern disclosures
Important for assessing solvency and continuity
SUNHYDROGEN, INC.
HYSR · Semiconductors & Related Devices
Thermon Group Holdings, Inc.
Electrical Industrial Apparatus
Green Planet Bio Engineering Co. Ltd.
GPLB · Biological Products, (No Diagnostic Substances)
Green Planet Bio Engineering Co.
Terra Innovatum Global N.V.
NKLR · Fabricated Plate Work (Boiler Shops)
Niagen Bioscience, Inc.
NAGE · Medicinal Chemicals & Botanical Products
Nuvve Holding Corp.
NVVE · Miscellaneous Electrical Machinery, Equipment & Supplies
: 29/04/2026